Growth Metrics

Corcept Therapeutics (CORT) EBITDA Margin Growth (3y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -40,178.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 530.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -932.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 7,003.00
10 Corcept Therapeutics 7.26 Bn 6.92 Bn 162.02 Mn -4,414.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4,414.00
Dec 31, 2025 -1,961.00
Sep 30, 2025 -2,647.00
Jun 30, 2025 -1,668.00
Mar 31, 2025 -2,096.00
Dec 31, 2024 -1,820.00
Sep 30, 2024 -607.00
Jun 30, 2024 -719.00
Mar 31, 2024 -924.00
Dec 31, 2023 -674.00
Sep 30, 2023 48.00
Jun 30, 2023 -745.00
Mar 31, 2023 -1,824.00
Dec 31, 2022 -1,154.00
Sep 30, 2022 -92.00
Jun 30, 2022 215.00
Mar 31, 2022 -531.00
Dec 31, 2021 -96.00
Sep 30, 2021 398.00
Jun 30, 2021 -32.00
Mar 31, 2021 -69.00
Dec 31, 2020 -15,431.00
Sep 30, 2020 -743.00
Jun 30, 2020 -297.00
Mar 31, 2020 1,644.00
Dec 31, 2019 1,406.00
Sep 30, 2019 2,041.00
Jun 30, 2019 2,330.00
Mar 31, 2019 2,856.00
Dec 31, 2018 2,202.00
Sep 30, 2018 2,685.00
Jun 30, 2018 3,899.00
Mar 31, 2018 6,991.00
Dec 31, 2017 21,858.00
Sep 30, 2017 10,225.00
Jun 30, 2017 14,803.00
Mar 31, 2017 30,777.00
Dec 31, 2016 26,305.00
Sep 30, 2016 38,168.00
Jun 30, 2016 57,518.00
Mar 31, 2016 63,721.00
Dec 31, 2015 73,579.00
Sep 30, 2015 72,788.00
Jun 30, 2015 85,790.00